Bradley Foster & Sargent Inc. CT significantly reduced its stake in Regeneron Pharmaceuticals, cutting its holdings by 68.1% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback